Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Asset Utilization Ratio (2024 - 2025)

Immunocore Holdings' Asset Utilization Ratio history spans 2 years, with the latest figure at 0.35 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 23.6% year-over-year to 0.35; the TTM value through Sep 2025 reached 0.35, up 23.6%, while the annual FY2024 figure was 0.39, 13.01% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.35 at Immunocore Holdings, up from 0.34 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.35 in Q3 2025 and bottomed at 0.28 in Q2 2024.